ModivCare Inc. (NASDAQ:MODV – Get Free Report) major shareholder Q Global Capital Management, L sold 262,532 shares of the stock in a transaction that occurred on Monday, January 13th. The stock was sold at an average price of $6.53, for a total transaction of $1,714,333.96. Following the completion of the sale, the insider now owns 1,221,933 shares of the company’s stock, valued at approximately $7,979,222.49. The trade was a 17.69 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
Q Global Capital Management, L also recently made the following trade(s):
- On Friday, January 10th, Q Global Capital Management, L purchased 3,837 shares of ModivCare stock. The stock was bought at an average cost of $12.61 per share, for a total transaction of $48,384.57.
- On Friday, December 6th, Q Global Capital Management, L acquired 9,210 shares of ModivCare stock. The shares were purchased at an average cost of $17.73 per share, with a total value of $163,293.30.
- On Wednesday, December 4th, Q Global Capital Management, L bought 3,352 shares of ModivCare stock. The stock was purchased at an average cost of $17.74 per share, for a total transaction of $59,464.48.
- On Monday, December 2nd, Q Global Capital Management, L purchased 1,583 shares of ModivCare stock. The shares were purchased at an average price of $17.75 per share, with a total value of $28,098.25.
- On Friday, November 29th, Q Global Capital Management, L acquired 198 shares of ModivCare stock. The stock was purchased at an average price of $17.75 per share, for a total transaction of $3,514.50.
- On Wednesday, November 27th, Q Global Capital Management, L bought 126 shares of ModivCare stock. The stock was acquired at an average price of $17.74 per share, with a total value of $2,235.24.
- On Thursday, November 21st, Q Global Capital Management, L purchased 23,657 shares of ModivCare stock. The shares were acquired at an average price of $16.92 per share, for a total transaction of $400,276.44.
- On Tuesday, November 19th, Q Global Capital Management, L acquired 21,411 shares of ModivCare stock. The stock was acquired at an average cost of $15.59 per share, with a total value of $333,797.49.
- On Thursday, November 7th, Q Global Capital Management, L acquired 58,191 shares of ModivCare stock. The stock was acquired at an average price of $17.13 per share, with a total value of $996,811.83.
- On Monday, November 4th, Q Global Capital Management, L bought 20,927 shares of ModivCare stock. The shares were bought at an average price of $16.13 per share, for a total transaction of $337,552.51.
ModivCare Stock Performance
NASDAQ:MODV traded up $0.09 during trading hours on Monday, hitting $6.65. 1,553,357 shares of the company traded hands, compared to its average volume of 748,006. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 103.63. The stock has a market capitalization of $94.99 million, a price-to-earnings ratio of -0.52, a P/E/G ratio of 2.77 and a beta of 0.60. The firm has a 50-day moving average of $15.07 and a 200 day moving average of $19.08. ModivCare Inc. has a twelve month low of $6.32 and a twelve month high of $52.33.
Analyst Ratings Changes
Several research firms have recently issued reports on MODV. Barrington Research reiterated an “outperform” rating and set a $25.00 price target on shares of ModivCare in a research note on Monday, November 18th. Stephens reaffirmed an “equal weight” rating and set a $17.00 target price (down previously from $21.00) on shares of ModivCare in a research report on Friday. Finally, Lake Street Capital dropped their price target on shares of ModivCare from $30.00 to $10.00 and set a “buy” rating on the stock in a research report on Monday. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $21.20.
Check Out Our Latest Analysis on ModivCare
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. Wilmington Savings Fund Society FSB acquired a new stake in ModivCare during the third quarter worth $43,000. Barclays PLC lifted its holdings in shares of ModivCare by 249.4% during the 3rd quarter. Barclays PLC now owns 15,235 shares of the company’s stock worth $218,000 after acquiring an additional 10,875 shares during the period. K2 Principal Fund L.P. boosted its position in shares of ModivCare by 24.6% during the 3rd quarter. K2 Principal Fund L.P. now owns 158,820 shares of the company’s stock valued at $2,268,000 after acquiring an additional 31,334 shares in the last quarter. State Street Corp increased its stake in ModivCare by 1.5% in the third quarter. State Street Corp now owns 349,750 shares of the company’s stock valued at $4,994,000 after acquiring an additional 5,115 shares during the period. Finally, Repertoire Partners LP acquired a new position in ModivCare in the third quarter worth about $178,000.
About ModivCare
ModivCare Inc, a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and Corporate and Other.
Featured Articles
- Five stocks we like better than ModivCare
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- What is the MACD Indicator and How to Use it in Your Trading
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What is a Stock Market Index and How Do You Use Them?
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for ModivCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ModivCare and related companies with MarketBeat.com's FREE daily email newsletter.